Thermo Fisher Scientific

The time for action is now

Overcoming challenges of the typical NGS workflow with the Ion Torrent Genexus System

With new EU regulations coming into effect for in vitro diagnostic medical devices, how can labs best prepare for the transition?

How to choose the right biomarker test for success in precision oncology

An expert panel discusses current progress and future possibilities to collaborate in the field of targeted therapy in lung cancer

Umberto Malapelle discusses his lab’s experience with onboarding precision medicine – and how other laboratories can follow in their footsteps

Healthcare management and patient care both benefit when oncology biomarker testing is performed in-house

Is comprehensive genomic profiling the next step in the evolution of genomics for oncology research and diagnostics?

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage the assays?